Visible waistline and body composition changes emerge in weeks three to six as the cumulative lipolytic effect on visceral fat accumulates
The retatrutide titration protocol reflects this by extending dose-escalation intervals to let glycaemic counter-regulation stabilise
What Makes Retatrutide Different And Why Its Not Yet Available Retatrutide is a newer triple agonist, targeting GLP1, GIP, and glucagon receptors
We excluded patients with bariatric surgery history and required weight measurements during baseline (90 days pre-treatment), the first year post-treatment (year 1), and the second year post-treatment (year 2), yielding 34,143 semaglutide-treated and 16,034 tirzepatide-treated patients ( Figure S1 )
The WHO noted that its future guidelines will focus on how to identify and prioritize individuals with the greatest need